Digital Realty Trust Inc DLR TRAK ReposiTrak posts 105 percent yearoveryear revenue growth slight EPS miss does not halt 15 percent share gain APT AlphaProTech reports 22 percent Q3 2025 revenue growth shares fall 325 percent on soft investor sentiment Hanmi HAFC Stock Extra Dividend 096 20260420 Wall Street Edges Lower as Crude Oil Rises on Iran Uranium Retention Reports US Markets Edge Higher as Chip Stocks Rally Ahead of Nvidia Earnings Dow Slips on Yield Concerns Omada Health OMDA Q1 2026 Earnings 005 EPS Surges Past 008 Estimates Prediction Market Investments Surge as Companies Push Ahead Despite Regulatory Uncertainty SP 500 MeltUp Potential Could the Index Reach 8000 or Beyond Kevin Warsh Poised for Internal Fed Clash Over Rate Cuts Amid Inflation and Yield Pressure US Jobless Claims Remain at Historically Low Levels Studds Accessories Reports 6 Profit Growth in Q4 FullYear Net Profit Up 187 to 827 Crore Enpro Inc NPO Q1 2026 Earnings Slight EPS Beat as Stock Gains on Operational Discipline PLG Q4 2023 Earnings SmallerThanExpected Loss Outpaces Analyst Estimates PED Q1 2026 Earnings Strong EPS Beat Offsets Investor Caution Amid Revenue Gap CRBP Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances VEON Q1 2026 Earnings EPS Beats Estimates as Stock Slips on Revenue Uncertainty Mesa Royalty Trust MTR Stages a 455 Rebound Key Levels in Focus BioLife Solutions BLFS Gains Ground Moving Toward Key Resistance at 2573 FGI Industries Surges Over 7 as Positive Momentum Builds Mount Logan Capital Gains 2 as Bulls Test Key Resistance Level Brinker International EAT Slips Amidst Trading Key Support Levels in Focus vTv Therapeutics VTVT Edges Lower Amid Consolidation Phase Estate Planning Quandary Navigating CD Inheritance for a Hospice Patients Six Heirs CUK Q1 2026 Earnings Slight EPS Miss Overshadowed by 656 Stock Rally Perpetua Resources Lands 29 Billion US ExportImport Bank Loan for Idaho Critical Minerals Project Trump Signals Possible Iran Nuclear Deal Decision by Sunday Axios Reports Dianthus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline Cyclerion Therapeutics CYCN Edges Higher Amid Quiet Trading